ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "neuroimaging and pain"

  • Abstract Number: 449 • 2018 ACR/ARHP Annual Meeting

    Pain Processing in Chronic Low Back Pain Individuals with or without Sick Leave

    Aloma Feitosa1, Liliana Jorge2, Liana Sanches2, Eduardo Ferreira Borba3, Edson Amaro2 and Ari Halpern1,2, 1Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SP, BR, Sao Paulo, Brazil, 2Instituto do Cérebro, Hospital Israelita Albert Einstein, Sao Paulo, Brazil, 3Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Chronic low back pain (LBP) is one of the most common musculoskeletal complaints in industrialized societies. It affects 80% of the adult population at…
  • Abstract Number: 2644 • 2012 ACR/ARHP Annual Meeting

    Functional Magnetic Resonance Imaging of Working Memory in Fibromyalgia: Support for a “Competing Demands” Theory of Cognitive Function in Chronic Pain

    Anson E. Kairys1, Gabriela Ramirez1, Eric Ichesco2, Johnson P. Hampson2, Richard E. Harris2, Daniel J. Clauw3, Tobias Schmidt-Wilcke2 and Jennifer M. Glass4, 1Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 2Anesthesiology, University of Michigan, Ann Arbor, MI, 3Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 4Psychiatry, University of Michigan, Ann Arbor, MI

    Background/Purpose: The primary symptom of fibromyalgia (FM) is chronic widespread pain; however, patients report additional symptoms including decreased concentration and memory. Deficits are seen mainly…
  • Abstract Number: 802 • 2012 ACR/ARHP Annual Meeting

    Milnacipran Reduces Brain Activity During Pain in Fibromyalgia

    Anson E. Kairys1, Richard E. Harris2, Eric Ichesco2, Johnson P. Hampson2, Steven Harte2, Daniel J. Clauw3 and Tobias Schmidt-Wilcke2, 1Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 2Anesthesiology, University of Michigan, Ann Arbor, MI, 3Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI

    Background/Purpose: Fibromyalgia (FM) is a chronic pain condition characterized by widespread musculoskeletal pain and a number of concomitant symptoms such as fatigue, sleep disturbance, cognitive…
  • Abstract Number: 805 • 2012 ACR/ARHP Annual Meeting

    Milnacipran Increases Cortical to Brainstem Connectivity During Pain in Fibromyalgia

    Eric Ichesco1, Tobias Schmidt-Wilcke1, Anson E. Kairys2, Johnson P. Hampson1, Steven E. Harte1, Daniel J. Clauw3 and Richard E. Harris1, 1Anesthesiology, University of Michigan, Ann Arbor, MI, 2Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 3Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI

    Background/Purpose: Fibromyalgia (FM) is a chronic widespread pain disorder characterized by muscle tenderness, fatigue, poor sleep, and mood disturbance.  Milnacipran is a dual serotonin-norepinephrine reuptake…
  • Abstract Number: 806 • 2012 ACR/ARHP Annual Meeting

    Posterior Insula Combined Glutamate and Glutamine Is Associated with Pain in Fibromyalgia: A Replication Study

    Eric Ichesco1, Daniel J. Clauw2, Steven E. Harte1, Anson E. Kairys3, Johnson P. Hampson1, Tobias Schmidt-Wilcke1 and Richard E. Harris1, 1Anesthesiology, University of Michigan, Ann Arbor, MI, 2Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 3Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI

    Background/Purpose: Central pain augmentation resulting from enhanced excitatory and/or decreased inhibitory neurotransmission is a proposed mechanism underlying the pathophysiology of functional pain syndromes such as…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology